Trends of Hospitalisation for Patients with Liver Cirrhosis in Ningxia, China: a Cross-sectional Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2023 Aug 22

PMID 37607786

Authors

Chao Shi

Hongjuan Shi

Chen Chen

Yining Liu

Yongtao Lv

Hua Zhang

Peifeng Liang

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the changing trends of hospitalisation for patients with liver cirrhosis between 2015 and 2019 by using hospitalisation summary records in Ningxia Hui Autonomous Region (NHAR), China.

Design: A cross-sectional study.

Setting: Hospitalisation summary records between 1 January 2015 and 31 December 2019 from 28 top-ranking hospitals in NHAR were extracted and rigorously analysed.

Participants: During the study period, hospitalisation records referring to liver cirrhosis were included. Records with missing data were excluded. A total of 16 566 patients with liver cirrhosis were included in this study.

Outcome Measures: International Classification of Diseases codes, tenth version (ICD-10) and text-diagnoses were used to identify hospitalisation records referring to liver cirrhosis.

Results: Between 2015 and 2019, hospitalisation rates for liver cirrhosis declined from 8.38% to 5.57%. Chronic viral hepatitis accounted for almost 70% of all liver cirrhosis admissions; the remaining 30% of patients were admitted due to non-viral hepatitis cirrhosis (28.06%) and alcoholic cirrhosis (2.05%). The male-to-female hospitalisation rate ratio for liver cirrhosis was 2.57. The hospitalisation rate for workers with hepatitis cirrhosis was significantly higher than farmers (hospitalisation rate ratio (RR)=1.06, 95% CI 1.01 to 1.15, p<0.001); this was also the case for alcoholic cirrhosis (RR=5.23, 95% CI 3.34 to 8.20). However, the hospitalisation rate for workers with non-viral hepatitis cirrhosis was significantly lower than for farmers (RR=5.23, 95% CI 3.34 to 8.20, p<0.001). The hospitalisation rate increased in patients over the age of 30 years and reached a peak at the age of 45-50 years.

Conclusions: The hospitalisation rate for liver cirrhosis has declined over recent years and chronic viral hepatitis remains the major cause of liver cirrhosis in NHAR. Hospitalisation summary records can efficiently reflect the local changing trends of hospitalisation for liver cirrhosis and represent an efficient strategy for the surveillance of chronic disease.

References

Bao X, Xu B, Fang K, Li Y, Hu Y, Yu G . Changing trends of hospitalisation of liver cirrhosis in Beijing, China. BMJ Open Gastroenterol. 2015; 2(1):e000051. PMC: 4650903. DOI: 10.1136/bmjgast-2015-000051. View

Li M, Wang Z, Zhang L, Zheng H, Liu D, Zhou M . Burden of Cirrhosis and Other Chronic Liver Diseases Caused by Specific Etiologies in China, 1990-2016: Findings from the Global Burden of Disease Study 2016. Biomed Environ Sci. 2020; 33(1):1-10. DOI: 10.3967/bes2020.001. View

Gu W, Hortlik H, Erasmus H, Schaaf L, Zeleke Y, Uschner F . Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg Health Eur. 2021; 12:100240. PMC: 8640738. DOI: 10.1016/j.lanepe.2021.100240. View

Tian H, Yang W, Hu Y, Liu Z, Chen L, Lei L . Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China. EClinicalMedicine. 2020; 20:100312. PMC: 7090368. DOI: 10.1016/j.eclinm.2020.100312. View

Shi C, Liu M, Liu Z, Guo C, Li F, Xu R . Using health insurance reimbursement data to identify incident cancer cases. J Clin Epidemiol. 2019; 114:141-149. DOI: 10.1016/j.jclinepi.2019.06.009. View

Wang Z, Wu Y, Wu J, Wang M, Wang X, Wang J . Trends in prevalence and incidence of type 2 diabetes among adults in Beijing, China, from 2008 to 2017. Diabet Med. 2020; 38(9):e14487. DOI: 10.1111/dme.14487. View

Wang X, Lin S, Tao J, Wei X, Liu Y, Chen Y . Study of liver cirrhosis over ten consecutive years in Southern China. World J Gastroenterol. 2014; 20(37):13546-55. PMC: 4188906. DOI: 10.3748/wjg.v20.i37.13546. View

. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018; 392(10152):1015-1035. PMC: 6148333. DOI: 10.1016/S0140-6736(18)31310-2. View

Perlman S, McVeigh K, Thorpe L, Jacobson L, Greene C, Gwynn R . Innovations in Population Health Surveillance: Using Electronic Health Records for Chronic Disease Surveillance. Am J Public Health. 2017; 107(6):853-857. PMC: 5425902. DOI: 10.2105/AJPH.2017.303813. View

10.

Li S, Zhang L, Liu S, Hubbard R, Li H . Surveillance of Noncommunicable Disease Epidemic Through the Integrated Noncommunicable Disease Collaborative Management System: Feasibility Pilot Study Conducted in the City of Ningbo, China. J Med Internet Res. 2020; 22(7):e17340. PMC: 7413277. DOI: 10.2196/17340. View

11.

Bell B, Manos M, Zaman A, Terrault N, Thomas A, Navarro V . The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol. 2008; 103(11):2727-36. DOI: 10.1111/j.1572-0241.2008.02071.x. View

12.

Blachier M, Leleu H, Peck-Radosavljevic M, Valla D, Roudot-Thoraval F . The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013; 58(3):593-608. DOI: 10.1016/j.jhep.2012.12.005. View

13.

Xiao J, Wang F, Wong N, He J, Zhang R, Sun R . Global liver disease burdens and research trends: Analysis from a Chinese perspective. J Hepatol. 2019; 71(1):212-221. DOI: 10.1016/j.jhep.2019.03.004. View

14.

Zhai M, Long J, Liu S, Liu C, Li L, Yang L . The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Aging (Albany NY). 2021; 13(1):279-300. PMC: 7835066. DOI: 10.18632/aging.104127. View

15.

Wang H, Men P, Xiao Y, Gao P, Lv M, Yuan Q . Hepatitis B infection in the general population of China: a systematic review and meta-analysis. BMC Infect Dis. 2019; 19(1):811. PMC: 6751646. DOI: 10.1186/s12879-019-4428-y. View

16.

Asrani S, Devarbhavi H, Eaton J, Kamath P . Burden of liver diseases in the world. J Hepatol. 2018; 70(1):151-171. DOI: 10.1016/j.jhep.2018.09.014. View

17.

Barnett R . Liver cirrhosis. Lancet. 2018; 392(10144):275. DOI: 10.1016/S0140-6736(18)31659-3. View

18.

. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020; 5(3):245-266. PMC: 7026710. DOI: 10.1016/S2468-1253(19)30349-8. View